Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants over 18 years of age with hypertension defined as sitting systolic blood pressure between 140 mmHg and 180 mmHg or sitting diastolic blood pressure between 90 mmHg and 120 mmHg.
High risk participants ( defined as having: (diabetes mellitus, chronic renal disease, Framingham 10-year risk score \>10%, established coronary artery disease (CAD), or CAD equivalents including carotid artery disease, peripheral arterial disease (PAD), abdominal aortic aneurysm (AAA))with hypertension defined as sitting systolic blood pressure between 130 mmHg and 180 mmHg or sitting diastolic blood pressure between 80 mmHg and 120 mmHg.
You may not be if
Known or suspected secondary hypertension
Known New York Heart Association (NYHA) functional class IV Heart Failure
History of myocardial infarction, transient ischemic attack or cerebrovascular accident within the preceding 3 months
Clinically significant valvular disease
Women who are pregnant, intend to become pregnant or are breastfeeding
Participants who have severe medical condition(s) that in the view of the Investigator prohibits participation in the study
Participants who have hypersensitivity to the investigational/ reference drug or any of the components in the formulation.
Clareo Health | To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
